Peer Supports for Augmentative and Alternative Communication
- Response deadline
- Jul 22, 2026 Closed
- Date posted
- Jun 22, 2026
- Source
- Open notice
Description
AoD plans to fund one (1) 3-year cooperative agreement to developsustainable peer support models for individuals who use or can benefit from the use of Augmentative and Alternative Communication (AAC) across the lifespan. The funded project must include, but not be limited to, individuals that use AAC, nonprofit community-based service-provider organization(s), self-advocacy organizations, youth and adults with I/DD, families, and others in their support system. The project will address the needs of and provide support for the estimated five million people in the US that experience speech disabilities including individuals intellectual and developmental disabilities (I/DD) who use AAC or could benefit from AAC to ensure access to needed community services, individualized supports, and other forms of assistance that promote self-determination, independence, productivity, and integration and inclusion in all facets of community life. The goal will be to provide a community where people who need or use AAC can come together in a safe space to share their positive and negative experiences and to increase knowledge, usage, and awareness of AAC for people with speech disabilities to live independent, self-determined lives using AAC that meets their interests and communicaion preferences.
Classifications
- NAICS93.631
Documents (1)
- Downloadhhs-2026-acl-aod-dnsa-0023_v2.pdfapplication/pdf328 KB
Contacts
Similar contracts
- Expanding Financial Literacy and Empowerment: Increasing Awareness and Use of ABLE Accounts for Americans with DisabilitiesDue Aug 3, 2026
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)Due May 26, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)Due Jan 10, 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027